Studies reveal a possible link between breast implants and lymphoma cancer
A rare condition
ALCL is a rare type of non-Hodgkin lymphoma (NHL) which is responsible for around 3% of NHL’s. Usually, this cancer type appears in the skin, lymph nodes, liver and soft tissue. However, ALCL can also on rare occasions appear in the breast. According to the research led by Dr Suzanna Turner of the University of Cambridge in the UK, almost all cases of ALCL development in the breast have occurred in patients who have had breast implants. Furthermore, the study discovered that the tumours are developing in the scar tissue surrounding the implant.
It should also be noted, that for the majority of these women developing breast implant-related ALCL, most of them responded well to treatment. In most cases, their cancer was successfully treated simply by removing their breast implant and the tissue surrounding it, rather than undergoing chemotherapy or radiotherapy.
The analysis of the risk is currently under dispute. Textured breast implants have been safely implemented in women’s breasts around the world for 30 years, and the connection to breast implant-related ALCL has not been established.
Self-examine your breasts
Dr David is one of the most experienced doctors in Melbourne in the use of the polyurethane foam covered implant, and has performed more than 800 breast augmentation procedures using these.
We recommend all breast augmentation patients, and women in general, to routinely do a self-examination of their breasts. If you notice any differences, don’t hesitate to see your GP or surgeon.
We encourage you to contact Dr David on 1800 745 536 if you have any further concerns about this, we are here to guide and support all patients.